Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00440895Phase 4Completed
Phase 4, randomised, double-blind trial of abciximab in acute myocardial infarction (AMI) (3 arms). Primary endpoints: TIMI score at 6 months and Myocardial Blush Grade at 6 months. Started Feb 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00440895.